A stem cell drug discovery company
Taylor Wessing LLP has offices in London and Cambridge and is a leading international law firm with 22 offices in Europe, the Middle East and Asia. We advise life science businesses, those who fund them and those who work for them. Our extensive Life Sciences Group combines lawyers from Taylor Wessing’s intellectual property, corporate, competition, dispute resolution and employment practices. The Group in the UK includes 15 lawyers with first degrees in life sciences subjects, of whom several have PhDs and many have spent periods working in the biotech and pharmaceutical industry.
No data available
Tesu Health is a prescription digital therapeutics company that aims to provide effective treatment options for individuals with chronic diseases.
Our mission is to enhance the quality of life for patients suffering from chronic diseases by developing evidence-based and clinically validated software that can be transformed into non-chemical and non-biological therapies. These therapies will not only halt but also reverse the progression of diseases by targeting their underlying causes.
Our vision at Tesu Health is to become a world-renowned digital therapeutics company that is at the forefront of developing innovative software therapies for chronic diseases.
Our mission is to enhance the quality of life for patients suffering from chronic diseases by developing evidence-based and clinically validated software that can be transformed into non-chemical and non-biological therapies. These therapies will not only halt but also reverse the progression of diseases by targeting their underlying causes.
Our vision at Tesu Health is to become a world-renowned digital therapeutics company that is at the forefront of developing innovative software therapies for chronic diseases.
No data available
CCDC are world-leading experts in structural chemistry data, software and knowledge for materials and life science research and application.
They are dedicated to the advancement of chemistry and crystallography for the public benefit. They specialise in the collation, preservation and application of scientific structural data for use in pharmaceutical discovery, materials development and research and education.
CCDC compile and distribute the Cambridge Structural Database (CSD), a certified trusted database of fully curated and enhanced organic and metal-organic structures, used by researchers across the globe.
Their cutting-edge software empowers scientists to extract invaluable insights from the vast dataset, informing and accelerating their research & development.
They are dedicated to the advancement of chemistry and crystallography for the public benefit. They specialise in the collation, preservation and application of scientific structural data for use in pharmaceutical discovery, materials development and research and education.
CCDC compile and distribute the Cambridge Structural Database (CSD), a certified trusted database of fully curated and enhanced organic and metal-organic structures, used by researchers across the globe.
Their cutting-edge software empowers scientists to extract invaluable insights from the vast dataset, informing and accelerating their research & development.
No data available
The Communications Strategy Group Inc. is a US-based consultancy providing corporate/financial communications and business development services to the life sciences, biotech and medical technology sectors; the firm assists and advises UK/EU companies seeking to expand to the US and provides corporate mentoring. CSG maintains strategic alliances with College Hill Life Sciences, London, and Cabinet Privé de Conseil s.a., Geneva.
The Institute of Cancer Research, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Scientists and clinicians at the ICR are working every day to make a real impact on cancer patients’ lives. Today, we are ranked as the UK’s leading academic research centre, and lead the world at isolating cancer-related genes and discovering new targeted cancer drugs. The ICR’s unique partnership with The Royal Marsden and ‘bench-to-bedside’ approach allows us to create and deliver results in a way that other institutions cannot.
No data available